Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Ford

Showing results (181-190 of 187) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 187 results.
JAMA Cardiology|March 19, 2020
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) TrialGuillaume Marquis-Gravel, Matthew T Roe, Holly R Robertson, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseW Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 19

Showing results (181-190 of 187) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 187 results.
JAMA Cardiology|March 19, 2020
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) TrialGuillaume Marquis-Gravel, Matthew T Roe, Holly R Robertson, et al.
Transfusion|August 3, 2023
Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trialsMoises A Huaman, Jay S Raval, James H Paxton, et al.
Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|March 30, 2022
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid J Sullivan, Kelly A Gebo, Shmuel Shoham, et al.
The New England Journal of Medicine|May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseW Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
JCI Insight|March 14, 2024
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trialHan-Sol Park, Anna Yin, Caelan Barranta, et al.
Pageof 19